Literature DB >> 28664531

The role of RhoC in malignant tumor invasion, metastasis and targeted therapy.

Xue Guan1, Shuo Chen1, Yang Zhao2.   

Abstract

As an important member of the RhoGTPase family, RhoC has various biological functions, such as regulating cytoskeleton reorganization, influencing cell adhesion, and migration. During recent decades, RhoC has been proven to be involved in the invasion and metastasis of malignant tumor and is thus a promising target of tumor therapy. This review focuses on the molecular mechanism of RhoC in invasion and metastasis of malignant tumors, as well as its research prospects as a potential target for tumor therapy.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28664531     DOI: 10.14670/HH-11-915

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  12 in total

Review 1.  Transcriptional and post-transcriptional regulation of the genes encoding the small GTPases RhoA, RhoB, and RhoC: implications for the pathogenesis of human diseases.

Authors:  Eirini Nomikou; Melina Livitsanou; Christos Stournaras; Dimitris Kardassis
Journal:  Cell Mol Life Sci       Date:  2018-03-02       Impact factor: 9.261

2.  Circular RNAs With Efficacy in Preclinical In Vitro and In Vivo Models of Esophageal Squamous Cell Carcinoma.

Authors:  Ulrich H Weidle; Tatjana Sela; Ulrich Brinkmann; Jens Niewoehner
Journal:  Cancer Genomics Proteomics       Date:  2022 May-Jun       Impact factor: 4.069

Review 3.  Role of miRNA-19a in Cancer Diagnosis and Poor Prognosis.

Authors:  Alessio Ardizzone; Giovanna Calabrese; Michela Campolo; Alessia Filippone; Dario Giuffrida; Francesca Esposito; Cristina Colarossi; Salvatore Cuzzocrea; Emanuela Esposito; Irene Paterniti
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

4.  RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer.

Authors:  Annapurna Pranatharthi; Pavana Thomas; Avinash H Udayashankar; Chandra Bhavani; Srinag Bangalore Suresh; Sudhir Krishna; Jayashree Thatte; Nirmala Srikantia; Cecil R Ross; Sweta Srivastava
Journal:  J Exp Clin Cancer Res       Date:  2019-09-05

5.  Twist2 is NFkB-responsive when p120-catenin is inactivated and EGFR is overexpressed in esophageal keratinocytes.

Authors:  Heather L Lehman; Michal Kidacki; Douglas B Stairs
Journal:  Sci Rep       Date:  2020-11-02       Impact factor: 4.379

6.  Circular RNA AKT3 governs malignant behaviors of esophageal cancer cells by sponging miR-17-5p.

Authors:  Hong-Liang Zang; Fu-Jian Ji; Hai-Ying Ju; Xiao-Feng Tian
Journal:  World J Gastroenterol       Date:  2021-01-21       Impact factor: 5.742

Review 7.  MiRNAs and Muscle Regeneration: Therapeutic Targets in Duchenne Muscular Dystrophy.

Authors:  Amelia Eva Aránega; Estefanía Lozano-Velasco; Lara Rodriguez-Outeiriño; Felicitas Ramírez de Acuña; Diego Franco; Francisco Hernández-Torres
Journal:  Int J Mol Sci       Date:  2021-04-19       Impact factor: 5.923

8.  GTPBP2 positively regulates the invasion, migration and proliferation of non-small cell lung cancer.

Authors:  Liu Jie; Li Cong; Wei Conghui; Gao Ying
Journal:  J Cancer       Date:  2021-05-05       Impact factor: 4.207

9.  Hematopoietic defects in response to reduced Arhgap21.

Authors:  Juliana Xavier-Ferrucio; Lauremília Ricon; Karla Vieira; Ana Leda Longhini; Mariana Lazarini; Carolina Louzão Bigarella; Gilberto Franchi; Diane S Krause; Sara T O Saad
Journal:  Stem Cell Res       Date:  2017-11-23       Impact factor: 2.020

10.  A novel isoform of ATOH8 promotes the metastasis of breast cancer by regulating RhoC.

Authors:  Mengyao Xu; Shan Huang; Xiaoli Dong; Yanan Chen; Miao Li; Wen Shi; Guanwen Wang; Chongbiao Huang; Qiong Wang; Yanhua Liu; Peiqing Sun; Shuang Yang; Rong Xiang; Antao Chang
Journal:  J Mol Cell Biol       Date:  2021-04-10       Impact factor: 6.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.